Synfacts, Inhaltsverzeichnis

Synfacts 2023; 19(06): 0619
DOI: 10.1055/s-0042-1752686

Innovative Drug Discovery and Development

A PhI CXCR3 Antagonist Making Progress in its Clinical Development for Inflammatory Disorders

Rezensent(en):

Antonia F. Stepan (Roche)

,

Erika A. Crane (Drug Hunter, Inc.)